Microvascular endothelial Kir channels in flow-induced dilation and hypertension
微血管内皮 Kir 通道在血流引起的扩张和高血压中的作用
基本信息
- 批准号:10392398
- 负责人:
- 金额:$ 62.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-19 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AKT1 geneAddressAnti-Inflammatory AgentsArteriesBiologyBlood PressureBlood VesselsBlood flowCardiovascular DiseasesCell membraneChargeComplexCouplesCouplingDataDepressed moodDevelopmentDiseaseElementsEndothelial CellsEndotheliumEventGenerationsGeneticGlycocalyxGoalsHarvestHeparitin SulfateHumanHypertensionImpairmentIn VitroInvestigationKDR geneKnock-outLinkMediatingMembraneMicrocirculationModelingMorbidity - disease rateMusNOS3 geneNitric OxideNitric Oxide SynthasePTEN genePatientsPersonsPhosphatidylinositol 4,5-DiphosphatePhospholipidsPhosphoric Monoester HydrolasesPhosphorylationPlayPotassium ChannelProductionProtein-Serine-Threonine KinasesRecoveryRecovery of FunctionRegulationRelaxationResearch DesignResistanceRoleSignal PathwaySignal TransductionTestingVascular Endothelial CellVasodilationVasodilator Agentsbaseblood pressure controlblood pressure elevationcohortfunctional losshemodynamicshypertensivehypertensivesinsightinward rectifier potassium channelmechanotransductionmortalitymouse modelnoveloverexpressionprehypertensionrecruitresponsesensorshear stresssyndecanvascular endothelial dysfunctionvirtual
项目摘要
Abstract:
Flow-induced vasodilation (FIV) is a hallmark of the endothelial response to flow and an
essential mechanism for the control of blood flow to the microcirculation. It is well established
that a key mechanism responsible for FIV is generation of nitric oxide (NO). Our recent study
discovered that FIV and flow-induced generation of NO in resistance arteries of mice and
humans critically depend on endothelial inwardly-rectifying K+ channels (Kir2.1). We also
established that Kir2.1 regulate endothelial NO synthase (eNOS) via a serine/threonine kinase
Akt1. This was particularly interesting and important because Kir channels have long been
known to be sensitive to shear stress but their role in endothelial responses to flow remained
unknown. The goals of this proposal are to determine the mechanisms by which Kir2.1 channels
couple hemodynamic shear stress forces to activation of endothelial NO synthase (eNOS) and
NO production and to evaluate the role of endothelial Kir channels in vasoreactivity of human
vessels in hypertension. Our first aim is to elucidate the mechanism responsible for the
sensitivity of Kir2.1 channels to shear stress, which is currently completely unknown. Our
preliminary data show that flow-sensitivity of Kir2.1 is abrogated by enzymatic degradation of
Heparan Sulphate (HS)-Glycocalyx and reduced in ECs isolated from Sydecan1-/- mice. We
propose, therefore, that flow-induced activation of Kir channels is mediated by the endothelial
Glycocalyx, specifically Syndecan-1, and possibly other elements of HS-Glycocalyx. We also
propose that Kir2.1 interacts directly with Syndecan-1, and elucidate the mechanism of this
interaction. Our second aim focuses on the mechanism that couples Kir2.1 to the downstream
Akt1 signaling pathway. It is well-known that flow-induced activation of AKT1 requires its
translocation and recruitment to the membrane via association with a phospholipid PIP3. We
propose that Kir enhances the association of Akt1 with PIP3 and thus facilitates its recruitment
to the membrane, resulting in increased Akt1 phosphorylation. We also explore the possibilities
that flow-induced activation of Kir2.1 may regulate the upstream events, such as activation PI3K
and its recruitment to VEGFR2 mechanosensing complex or inhibit a phosphatase PTEN that
converts PIP3 to PIP2. This signaling mechanism is explored in primary endothelial cells and in
intact resistance arteries freshly-harvested from mice. A new endothelial-specific inducible
mouse model of Kir2.1 deficiency has been generated in our lab to achieve these goals. In aim
3, we propose to test the hypothesis that microvascular endothelial Kir function is depressed
during human hypertension. This aim is based on our preliminary data showing decreased
contribution of Kir2.1 to FIV in a pilot cohort of hypertensive patients. In this study, we will recruit
3 groups of subjects that include patients with pre-hypertension or stage 1 hypertension and
healthy controls. We will also determine whether the loss of Kir2.1 contribution to FIV should be
attributed to the loss of the functional expression of Kir2.1 channels or to their impaired coupling
to the downstream signaling. Finally, we will also determine whether impaired FIV in
hypertensive patients may be rescued by restoring Kir2.1 activity.
文摘:
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effective Parameters Controlling Sterol Transfer: A Time-Resolved Small-Angle Neutron Scattering Study
控制甾醇转移的有效参数:时间分辨小角中子散射研究
- DOI:10.1007/s00232-022-00231-3
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Perez-Salas, Ursula;Porcar, Lionel;Garg, Sumit;Ayee, Manuela A.;Levitan, Irena
- 通讯作者:Levitan, Irena
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Irena Levitan其他文献
Irena Levitan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Irena Levitan', 18)}}的其他基金
Cholesterol Regulation of Endothelial K+ Channels
内皮 K 通道的胆固醇调节
- 批准号:
10836797 - 财政年份:2022
- 资助金额:
$ 62.39万 - 项目类别:
Microvascular endothelial Kir channels in flow-induced dilation and hypertension
微血管内皮 Kir 通道在血流引起的扩张和高血压中的作用
- 批准号:
9917815 - 财政年份:2019
- 资助金额:
$ 62.39万 - 项目类别:
Impact of dyslipidemia on endothelial biomechanics
血脂异常对内皮生物力学的影响
- 批准号:
7877943 - 财政年份:2007
- 资助金额:
$ 62.39万 - 项目类别:
Impact of dyslipidemia on endothelial biomechanics
血脂异常对内皮生物力学的影响
- 批准号:
9041643 - 财政年份:2007
- 资助金额:
$ 62.39万 - 项目类别:
Impact of dyslipidemia on endothelial biomechanics
血脂异常对内皮生物力学的影响
- 批准号:
10201709 - 财政年份:2007
- 资助金额:
$ 62.39万 - 项目类别:
Impact of dyslipidemia on endothelial biomechanics
血脂异常对内皮生物力学的影响
- 批准号:
7492115 - 财政年份:2007
- 资助金额:
$ 62.39万 - 项目类别:
Impact of dyslipidemia on endothelial biomechanics
血脂异常对内皮生物力学的影响
- 批准号:
9789917 - 财政年份:2007
- 资助金额:
$ 62.39万 - 项目类别:
Impact of dyslipidemia on endothelial biomechanics
血脂异常对内皮生物力学的影响
- 批准号:
7643248 - 财政年份:2007
- 资助金额:
$ 62.39万 - 项目类别:
Impact of dyslipidemia on endothelial biomechanics
血脂异常对内皮生物力学的影响
- 批准号:
7321162 - 财政年份:2007
- 资助金额:
$ 62.39万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 62.39万 - 项目类别:
Research Grant